UBS Group AG - TENAYA THERAPEUTICS INC ownership

TENAYA THERAPEUTICS INC's ticker is and the CUSIP is 87990A106. A total of 48 filers reported holding TENAYA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of TENAYA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$64,984
-57.9%
25,484
-3.2%
0.00%
Q2 2023$154,504
+268.1%
26,321
+78.7%
0.00%
Q1 2023$41,978
+73.2%
14,729
+22.1%
0.00%
Q4 2022$24,241
+2324.1%
12,060
+4520.7%
0.00%
Q2 2022$1,000
-75.0%
261
-28.9%
0.00%
Q1 2022$4,000
-93.5%
367
-88.8%
0.00%
Q4 2021$62,000
+675.0%
3,290
+777.3%
0.00%
Q3 2021$8,0003750.00%
Other shareholders
TENAYA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Column Group LLC 9,400,290$23,970,74015.92%
Casdin Capital, LLC 6,381,377$16,272,5111.80%
Trustees of Columbia University in the City of New York 291,828$744,1621.37%
Euclidean Capital LLC 2,031,410$5,180,0960.56%
RA Capital Management 6,718,483$17,132,1320.34%
StepStone Group LP 462,163$1,178,5160.26%
HARVARD MANAGEMENT CO INC 673,270$1,7170.19%
Alphabet Inc. 915,705$2,335,0470.15%
GSA CAPITAL PARTNERS LLP 363,493$9270.08%
ATTICUS WEALTH MANAGEMENT, LLC 80,037$204,0950.08%
View complete list of TENAYA THERAPEUTICS INC shareholders